Bacterial pneumonia in the AIDS patients

West African Journal of Medicine

Volumn 25, Issue 1, 2006, Pages 1-5

  Salami, A K ^a   Olatunji, P O ^a   Oluboyo, P O ^a   Akanbi II, A A ^a   Fawibe, E A ^a  

^a UNIVERSITY OF ILORIN   (Nigeria)

Author keywords

AIDS; Bacterial pathogen and prognostic factors; Pneumonia

Indexed keywords

AMOXICILLIN PLUS CLAVULANIC ACID; CEFTRIAXONE; CEFUROXIME; CIPROFLOXACIN; GENTAMICIN; LAMIVUDINE; NEVIRAPINE; STAVUDINE; SULTAMICILLIN;

ACQUIRED IMMUNE DEFICIENCY SYNDROME; ADULT; ANTIBIOTIC THERAPY; ARTICLE; BACTEREMIA; BACTERIAL PNEUMONIA; BACTERIUM CULTURE; BACTERIUM ISOLATION; BLOOD CULTURE; CD4 LYMPHOCYTE COUNT; CLINICAL FEATURE; COMMUNITY ACQUIRED PNEUMONIA; DISEASE SEVERITY; ESCHERICHIA COLI; FEMALE; HIGHLY ACTIVE ANTIRETROVIRAL THERAPY; HUMAN; IMMUNE DEFICIENCY; INCIDENCE; KLEBSIELLA PNEUMONIAE; MAJOR CLINICAL STUDY; MALE; PROGNOSIS; PSEUDOMONAS AERUGINOSA; SENSITIVITY ANALYSIS; SPUTUM CULTURE; SPUTUM CYTODIAGNOSIS; STAPHYLOCOCCUS AUREUS; STREPTOCOCCUS PNEUMONIAE; THORAX RADIOGRAPHY; TREATMENT OUTCOME;

ACQUIRED IMMUNODEFICIENCY SYNDROME; ADULT; AIDS-RELATED OPPORTUNISTIC INFECTIONS; ANTI-BACTERIAL AGENTS; COMMUNITY-ACQUIRED INFECTIONS; COMORBIDITY; ESCHERICHIA COLI; FEMALE; HUMANS; INCIDENCE; KLEBSIELLA PNEUMONIAE; MALE; MIDDLE AGED; NIGERIA; PNEUMONIA, BACTERIAL; PROGNOSIS; PROSPECTIVE STUDIES; PSEUDOMONAS AERUGINOSA; SPUTUM; STAPHYLOCOCCUS AUREUS; STREPTOCOCCUS PNEUMONIAE; TREATMENT OUTCOME;

EID: 33646835615     PISSN: 0189160X     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (33)

1. Witt DJ, Craven DE, McCabe DR. Bacterial infection in patients with acquired immune deficiency syndrome and AIDS-related complex. Am J Med. 1987; 82: 900-906.
2. Polsky B, Gold JWM, Whimbey E et al. Bacterial Pneumonia in Patients with the acquired immune deficiency syndrome. Ann Intern Med. 1986; 104: 38-41.
3. Simberkoff MS, El Sadr W, Schiffman G et al. Streptococcus pneumoniae infections and bacteremia in patients with acquired immune deficiency syndrome and pneumococcal vaccine failure. Am Rev Respir Dis. 1984; 130: 1174-1176.
4. Selwyn PA, Alcabes P, Hartel D et al. Clinical manifestation of and predictors of disease progression in drug users with human immunodeficiency virus infection. N Engl J Med. 1992; 327: 1697-1703.
5. Magnenat J, Nicod LP, Auckanthaler R et al. Mode of diagnosis of bacterial pneumonia in human immunodeficiency virus infected patients. Am Rev Resp Dis. 1991; 144: 917-922.
6. Wallace JM, Rao AV, Glasstoth J et al. Respiratory illness in persons with human immunodeficiency virus infection. Am Rev Resp Dis. 1993; 148: 1523-1529.
7. Nichols L, Balogh K, Silverman M. Bacterial infections in the acquired immunodeficiency syndrome: Clinicopathology correlation in a series of autopsy cases. Am J Clin Pathol. 1989; 92: 787-790.
8. Macher AM: Infection in the acquired immunodeficiency syndrome. In: Fauci AS, moderator. Acquired immunodeficiency syndrome: Epidemiologic, clinical, immunologic and therapeutic considerations. Ann Intern Med. 1984; 100: 92-106.
9. Lane HC, Masur H, Edgar LC, Whalen G, Rook H, Fauci AS. Abnormality of B-cell activation abnormal immunoregulation in patients with the acquired immune deficiency syndrome. N Engl J Med. 1983; 309: 453-458
10. Pahwa SG, Quilop MTJ, Lange M et al. Defective B-lymphocyte function in Homosexual men in relation to acquired immune deficiency syndrome. Ann Intern Med. 1984; 101: 757-763.
11. Hirschstick RE, Glassroth J, Jordan MC et al. Bacterial pneumonia in persons infected with human immunodeficiency virus. N Engl J Med. 1995; 333: 845-851.
12. Hanson DC, Chubsy SY, Feriso KM, et al. Distribution of CD4 lymphocytes at diagnosis of AIDS and other HIV-related illness. Arch Inter Med. 1995; 155: 1535-1537.
13. Casadevall A, Dobroszycki A, Small C et al. Haemophillus influenzae type b bacteremia in adults with AIDS and at risk for AIDS. Am J Med. 1992; 92: 587-590.
14. Harlan MK, Merle AS, Bernard LO. Community acquired bacteremia in patients with acquired immunodeficiency syndrome: clinical presentation, bacteriology and outcome. Am J Med. 1989; 86: 776-779.
15. Fine M, Smith MA, Carson CA et al. Prognosis and outcome of patients with community acquired pneumonia: a meta-analysis. JAMA. 1996; 275: 134-141.
16. Dropulic LK, Leslie JM, Eldred LJ et al. Clinical manifestation and risk factors of Pseudomonas aeruginosa in AIDS patients. J Infect Dis. 1996; 171: 930-937.
17. Barlett JG. Community acquired pneumonia: Respiratory Disease in the Immunosuppressed Host. JB Lippincott Company. Philadelphia. 1st edition 1991. Page 235-236.
18. Salami AK, Oluboyo PO. Hospital prevalence of PTB and Co-infection with HIV infection in Ilorin: A review of nine years. West Afr J Med. 2002; 21: 24-27.
19. Barret-Connor E. The non-value of sputum culture in the diagnosis of pneumococcal pneumonia. Am Rev Respir Med. 1971; 103: 845-848.
20. Janof EN, Breiman RF, Daley CL, et al. Pneumococcal disease during HIV infection: epidemiologic, clinical and immunologic perspectives. Ann. Intern Med. 1992; 117: 314-324
21. Muller F, Froland SS, Hvatum M et al. Both Ig A subclasses are reduced in parotid saliva from patients with AIDS. Clin Exp Immunol. 1991; 83: 203-209.
22. Toews GB. Predisposition to respiratory disease: immunologic and non-immunologic factors, page 415-418. In Shelhamer JH, moderator. Respiratory disease in immunocompromised patients. Ann Intern Med. 1992; 117: 415-431.
23. Fang GD, Fine M, Orloff J et al. New and emerging etiologies for community acquired pneumonia with implication for therapy: a prospective multicentre study of 359 cases. Medicine (Baltimore). 1990; 69: 307-316.
24. Bates JH, Campbell GD, Barron AL et al. Microbial etiology of acute pneumonia in Hospitalized patients. Chest. 1992; 101: 1005-1012.
25. Ogunsola FT. Penicillin-Resistant Pneumococcus. Nig Qt J Hosp Med. 1997; 7: 120-128.
26. Cohn DL. Bacterial pneumonia in the HIV-infected patient. Infect Dis Clin North Am. 1991; 5: 485-507.
27. Garcia-Leoni ME, Moreno S, Rodeno P et al. Pneumococcal pneumonia in adults hospitalized HIV-infected patients. Arch Intern Med. 1992; 152: 1808-1812.
28. Pachos J, Prados D, Capite F et al. Severe community acquired pneumonia. Aetiology, prognosis and treatment. Am Rev Resp Dis. 1990; 142: 369-373.
29. Ruiz M, Ewig S, Marcos MA et al. Etiology of community-acquired pneumonia: impact of age, comorbidity, and severity. Am J Respir Crit Care Med. 1999; 160: 397-405.
30. Ogunsola FT, Oduyebo OO, Kesah CN et al. The prevalence and antibiotic susceptibility patterns of various Klebsiella species in clinical samples and the implication for the control of hospital-acquired infections. Nig Qt J Hosp Med. 1998; 8: 158-163.
31. Ozumba UC. Antibiotic sensitivity of isolates of Pseudomonas aeruginosa in Enugu, Nigeria. Afr J Clin Exp microbiol. 2003; 4: 48-51.
32. Oduyebo O, Ogunsola FT, Odugbemi T. Prevalence of Multi-resistant strains of Pseudomonas aeruginosa isolated at the Lagos University Teaching Hospital Laboratory from 1994-1996. Nig Qt J Hosp Med. 1997; 7: 373-376.
33. Craven DE, Steger KA, Marc Larfoce F. Pneumonia: Human immunodeficiency virus and emerging pathogens, fourth edition. Lippincott-Raven publishers, Philadelphia. 1998 page 487-506.